Mackay Shields LLC Iovance Biotherapeutics, Inc. Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$27.75 - $36.3 $666,000 - $871,199	-24,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$27.21 - $41.0 $1.34 Million - $2.01 Million	-49,138 Reduced 67.19%	24,000 $659,000
Q1 2020 May 08, 2020	SELL	$19.54 - $38.85 $103,562 - $205,905	-5,300 Reduced 6.76%	73,138 $2.19 Million
Q4 2019 Feb 11, 2020	SELL	$17.95 - $29.41 $86,160 - $141,168	-4,800 Reduced 5.77%	78,438 $2.17 Million
Q3 2019 Nov 01, 2019	SELL	$17.99 - $26.0 $57,567 - $83,200	-3,200 Reduced 3.7%	83,238 $1.52 Million
Q2 2019 Aug 13, 2019	BUY	$9.78 - $24.52 $428,559 - $1.07 Million	43,820 Added 102.82%	86,438 $2.12 Million
Q1 2019 May 13, 2019	BUY	$8.41 - $11.26 $76,531 - $102,466	9,100 Added 27.15%	42,618 $405,000
Q4 2018 Feb 14, 2019	SELL	$7.51 - $11.93 $7,374 - $11,715	-982 Reduced 2.85%	33,518 $297,000
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $388,125 - $610,650	34,500 New	34,500 $388,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.